Inflammation and Brain Disorders: A series of Articles
Neuroinflammation, either directly occurring in the brain from microglial activation or indirectly from peripherally generated immune modulators, is becoming apparent as a component of a number of brain disorders, including Alzheimer’s disease, depression, bipolar disorder and schizophrenia.
In familial disease associated with PSEN-1 mutations, symptomatic carriers show progressive loss of cortical thickness in areas involved in Alzheimer’s Disease (AD).
This article addresses the blood-borne factors related to inflammation and aging, heterogeneity within schizophrenia and the hypothesis that people with schizophrenia experience pathological aging
This article investigates Major Depressive Disorder (MDD) and the relationship between inflammatory markers and treatment response and resistance.